Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route (V205C-011)
Clinical trial NCT00432523 · COMPLETED
Trial details
- NCT number
- NCT00432523
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-20
- Primary completion
- 2005-09-05
- Enrollment
- 752
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.